Literature DB >> 127927

The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).

C D Marsden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 127927

Source DB:  PubMed          Journal:  Mod Trends Neurol        ISSN: 0544-6872


× No keyword cloud information.
  8 in total

1.  Treatment of chronic schizophrenia.

Authors:  D A Johnson
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

2.  The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings].

Authors:  D N Bateman; D K Dutta; H A McClelland; M D Rawlins
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

3.  Reversible spastic and pyramidal tract signs in a patient with Parkinson's disease on L-dopa.

Authors:  S Seyfert; M Straschill
Journal:  J Neurol       Date:  1977-10-07       Impact factor: 4.849

4.  Acute dystonic reactions to neuroleptic drugs.

Authors:  R L Cooper; S B Milam; L K Croft
Journal:  Anesth Prog       Date:  1984 Jul-Aug

5.  Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics.

Authors:  D Chadwick; E H Reynolds; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

6.  Oxiperomide in tardive dyskinesia.

Authors:  D E Casey; J Gerlach
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-03       Impact factor: 10.154

7.  Levodopa and Huntington's chorea.

Authors:  C Loeb; G Roccatagliata; G La Medica; G Abbruzzese; C Albano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-10       Impact factor: 10.154

8.  A study of prophylactic value of antiparkinsonian drug.

Authors:  P B Behere; P Ramakrishna
Journal:  Indian J Psychiatry       Date:  1983-07       Impact factor: 1.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.